Personalis, Inc. (PSNL) Stock

Personalis, Inc. (PSNL) is a Healthcare stock trading at $10.52 (as of 2026-06-18), with a market capitalization of $1.19B and a trailing P/E of -11.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Personalis, Inc. provides cancer genomics sequencing and analytical services, including its NeXT platform for profiling tumors or tumor signals from limited tissue or plasma samples and for related biomarker and neoantigen analysis, and its ACE platform for clinical and therapeutic applications. It serves biopharmaceutical companies, academic institutions, non-profits, and government entities.

Valuation — source: SEC EDGAR (first-party)
Price$10.52
Market Cap$1.19B
P/E Ratio-11.2
EV / EBITDA-12.1
Price / Book4.69
Price / Sales18.50
DCF Value (model)$-11.74
DCF Upside vs Price-211.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$69.65M
Net Margin-116.7%
Return on Equity-37.5%
Current Ratio6.61
Revenue Growth (YoY)-24.9%
EPS Growth (YoY)61.1%
FCF Growth (YoY)25.4%
Financial Health — source: SEC EDGAR
Altman Z-Score6.56 (safe)
Valuation vs Sector & Industry
Stock P/E-11.2
Sector P/E (Healthcare)21.0
Industry P/E (Healthcare Services)23.0
vs Sector-153.3%
vs Industry-148.5%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderMerck & Co., Inc. ($89.47M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEOChristopher Hall
Employees228
CountryUS
IPO Date2019-06-20

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Anbio Biotechnology Class A Ordinary Shares (NNNN)
  • Neogen Corporation (NEOG)
  • Castle Biosciences, Inc. (CSTL)
  • CareDx, Inc (CDNA)
  • Fulgent Genetics, Inc. (FLGT)
  • Myriad Genetics, Inc. (MYGN)
  • Absci Corporation (ABSI)
  • National Research Corporation (NRC)
PSNL earnings history · PSNL institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.